NF2 Gene Neurofibromatosis Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين NF2 للورم العصبي الليفي من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

✓ Accuracy Guarantee:

99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing – detecting even low‑frequency NF2 pathogenic variants.

✓ Premium Logistics:

Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM–11 PM).

✓ Clinical Guidance:

Telephonic post‑test clinical guidance in result interpretation by DHA‑licensed genetic counsellors.

✓ Insurance:

Direct Billing Verification via WhatsApp +971 54 548 8731 — we confirm coverage before your draw.

يضمن مركزنا دقة تشخيصية بنسبة 99.9% لطفرة جين NF2 باستخدام تقنية التسلسل الجيني المتقدم تحت إشراف هيئة الصحة بدبي.

Test Overview

The NF2 Gene Neurofibromatosis Type 2 Genetic Test is a comprehensive next‑generation sequencing assay that analyzes the entire coding region of the NF2 gene for pathogenic mutations associated with Neurofibromatosis type 2. يُستخدم هذا الاختبار الجيني للكشف عن الطفرات المسببة للورم العصبي الليفي من النوع الثاني.

Feature	Our Test (NGS)	Traditional Sanger Sequencing
Diagnostic Sensitivity	99.9% (complete gene coverage)	~95% (only targeted exons)
Turnaround Time	3–4 Weeks	6–8 Weeks
Price (AED)	2800	3500
Method	NGS (Illumina® platform)	Capillary Electrophoresis

Physician Insight & Safety Protocol

A Note from Dr. Prabhakar Reddy (DHA License: 61713011):

"As a clinician, I emphasize that a positive NF2 mutation result confirms susceptibility but does not define your clinical destiny. Every genetic finding must be correlated with thorough neurological, dermatological, and audiological evaluation. Your care team will use this molecular data to tailor surveillance and timely interventions, because early detection of vestibular schwannomas or meningiomas dramatically improves outcomes."

‼ Medication Warning:

Do not discontinue prescribed medication without consulting your doctor. Beta‑blockers, anticonvulsants, or other agents used for symptom management must be reviewed only by your treating physician in light of genetic results.

Patient Safety Information

Exclusion Criteria: Individuals unable to provide informed consent, minors without a legal guardian present (as per CDS Law 2026), and patients with active febrile illness on collection day.
ER Red Flags: Sudden hearing loss, tinnitus, imbalance, facial weakness, visual disturbances, or severe headache – seek emergency care immediately. These may indicate expanding cranial tumors requiring urgent imaging.

Patient FAQ & Clinical Guidance

1. What does the NF2 gene test detect?

This NGS panel detects germline pathogenic variants (single nucleotide, small indels, and copy number changes) across the entire NF2 coding region, confirming hereditary Neurofibromatosis type 2 predisposition. It identifies mutations responsible for bilateral vestibular schwannomas, meningiomas, and spinal tumors even before symptoms appear, enabling proactive surveillance and family cascade testing.

2. ما هو تحليل جين NF2؟

يقوم تحليل جين NF2 عبر تقنية التسلسل الجيني المتقدم بالكشف عن الطفرات الوراثية المسببة للورم العصبي الليفي من النوع الثاني. يُستخدم الاختبار لتأكيد التشخيص لدى الأشخاص الذين يعانون من ورم العصب السمعي الثنائي أو تاريخ عائلي للمرض، ويتيح إجراء فحوصات استباقية لأفراد العائلة.

3. How do I prepare for the test?

Provide a detailed three‑generation family pedigree during the mandatory pre‑ genetic counseling session, and avoid heavy physical exertion or alcohol for 24 hours before blood collection. Our nurse will collect 5 mL whole blood (or a single drop on an FTA card) using a hospital‑grade cold‑chain kit. A clinical history form is required; genetic counsellors will guide you through consent and pedigree documentation.

دعم ثنائي اللغة متاح